TrialBritish journal of clinical pharmacology2020

Randomized study of the effect of gadopiclenol, a new gadolinium-based contrast agent, on the QTc interval in healthy subjects.

Christian Funck-Brentano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.